Q2 2026 Holdings
Filed 2026-08-17 | 52 holdings | $723.7M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2026-08-19) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $75.0M | 918,846 | 10.4% |
| Acadia Pharmaceuticals Inc(ACHC) | COM | 00404A109 | $72.5M | 2,864,096 | 10.0% |
| Acadia Pharmaceuticals Inc(ACAD)A | COM | 004225108 | $72.5M | 2,864,096 | 10.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $44.1M | 413,980 | 6.1% |
| Mirum Pharmaceuticals Inc | NOTE 4.000% 5/0 | 604749AB7 | $40.8M | $348,808 | 5.6% |
| Mirum Pharmaceuticals Inc(MIRM)A | COM | 604749101 | $40.8M | 348,808 | 5.6% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $40.7M | 603,489 | 5.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $39.1M | 682,777 | 5.4% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $36.6M | 1,647,521 | 5.1% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $33.9M | 62,587 | 4.7% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $30.5M | 416,646 | 4.2% |
| Biogen Inc(BIIB) | COM | 09062X103 | $30.3M | 140,279 | 4.2% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $22.0M | 5,296,209 | 3.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $19.9M | 596,495 | 2.8% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $19.4M | 1,280,439 | 2.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $18.9M | 864,986 | 2.6% |
| Annexon Inc(ANNX) | COM | 03589W102 | $16.8M | 2,948,090 | 2.3% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $16.3M | 550,408 | 2.3% |
| Caredx Inc(CDNA) | COM | 14167L103 | $15.2M | 531,870 | 2.1% |
| Celldex Therapeutics Inc(CLDX) | COM NEW | 15117B202 | $14.9M | 399,856 | 2.1% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $12.8M | 5,831,813 | 1.8% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $12.7M | 242,560 | 1.8% |
| First Tracks Biotherapeutics(TRAX) | ORD SHS | 337185102 | $12.1M | 603,489 | 1.7% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $11.2M | 1,143,155 | 1.5% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $9.5M | 167,525 | 1.3% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $9.5M | 1,391,382 | 1.3% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $8.5M | 1,613,430 | 1.2% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $7.9M | 213,601 | 1.1% |
| Capricor Therapeutics Inc(CAPR) | COM NEW | 14070B309 | $5.5M | 229,763 | 0.8% |
| Align Technology Inc(ALGN) | COM | 016255101 | $5.3M | 31,389 | 0.7% |
| Oruka Therapeutics Inc - Restricted(ORKA) | COM | 687604108 | $3.2M | 33,546 | 0.4% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $3.1M | 51,345 | 0.4% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $3.1M | 18,117 | 0.4% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $3.0M | 33,640 | 0.4% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $2.8M | 84,631 | 0.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $2.7M | 32,195 | 0.4% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $2.6M | 864,277 | 0.4% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $2.2M | 1,482,797 | 0.3% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $2.2M | 39,605 | 0.3% |
| Sagimet Biosciences Inc(SGMT) | COM SER A | 786700104 | $1.9M | 250,000 | 0.3% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $1.9M | 326,609 | 0.3% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $1.8M | 19,614 | 0.3% |
| Compass Pathways PLC ADR(CMPS) | SPONSORED ADS | 20451W101 | $1.6M | 115,616 | 0.2% |
| Humana Inc(HUM) | COM | 444859102 | $1.6M | 3,985 | 0.2% |
| Newamsterdam Pharma Co NV(NAMS) | ORDINARY SHARES | N62509109 | $1.5M | 44,359 | 0.2% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $1.2M | 309,685 | 0.2% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $959.5K | 1,787 | 0.1% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $901.6K | 24,500 | 0.1% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $856.0K | 201,890 | 0.1% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $826.9K | 104,410 | 0.1% |